These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2798938)

  • 1. Comparison of the predictions of the LQ and CRE models for normal tissue damage due to biologically targeted radiotherapy with exponentially decaying dose rates.
    O'Donoghue JA
    Radiother Oncol; 1989 Aug; 15(4):359-62. PubMed ID: 2798938
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanistic formulation of a lineal-quadratic-linear (LQL) model: split-dose experiments and exponentially decaying sources.
    Guerrero M; Carlone M
    Med Phys; 2010 Aug; 37(8):4173-81. PubMed ID: 20879577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
    Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
    Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoeffect relationships for fractionated biologically targeted radiotherapy.
    O'Donoghue JA
    Radiother Oncol; 1990 Nov; 19(3):257-65. PubMed ID: 2281155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy.
    Gay HA; Sibata CH; Allison RR; Jeremic B
    Radiother Oncol; 2009 Jun; 91(3):369-78. PubMed ID: 19058867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.
    Dale RG
    Br J Radiol; 1985 Jun; 58(690):515-28. PubMed ID: 4063711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and radiobiologic evaluation of radiation dosage in radiotherapy of vaginal cancer].
    Kanaev SV; Turkevich VG
    Vopr Onkol; 1996; 42(6):44-7. PubMed ID: 9123901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.
    Unkel S; Belka C; Lauber K
    Radiat Oncol; 2016 Jan; 11():11. PubMed ID: 26822015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the linear-quadratic radiobiological model for quantifying kidney response in targeted radiotherapy.
    Dale R
    Cancer Biother Radiopharm; 2004 Jun; 19(3):363-70. PubMed ID: 15285884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
    Guerrero M; Li XA
    Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biological effect of inhomogeneous dose distributions in fractionated radiotherapy.
    Yaes RJ
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):203-7. PubMed ID: 2380086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model.
    Shibamoto Y; Otsuka S; Iwata H; Sugie C; Ogino H; Tomita N
    J Radiat Res; 2012; 53(1):1-9. PubMed ID: 21997195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
    King CR; DiPetrillo TA; Wazer DE
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 1989 James Kirk memorial lecture. The potential for radiobiological modelling in radiotherapy treatment design.
    Dale RG
    Radiother Oncol; 1990 Nov; 19(3):245-55. PubMed ID: 2281154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cellular repair and proliferation on targeted radionuclide therapy: a modelling study.
    Atthey M; Nahum AE; Flower MA; McCready VR
    Phys Med Biol; 2000 Apr; 45(4):N15-20. PubMed ID: 10795994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry in nuclear medicine therapy: radiobiology application and results.
    Strigari L; Benassi M; Chiesa C; Cremonesi M; Bodei L; D'Andrea M
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):205-21. PubMed ID: 21386791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
    van Leeuwen CM; Oei AL; Crezee J; Bel A; Franken NAP; Stalpers LJA; Kok HP
    Radiat Oncol; 2018 May; 13(1):96. PubMed ID: 29769103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The radiobiology of conventional radiotherapy and its application to radionuclide therapy.
    Dale R; Carabe-Fernandez A
    Cancer Biother Radiopharm; 2005 Feb; 20(1):47-51. PubMed ID: 15778580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.
    Brenner DJ; Hlatky LR; Hahnfeldt PJ; Huang Y; Sachs RK
    Radiat Res; 1998 Jul; 150(1):83-91. PubMed ID: 9650605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.